Niraparib In Recurrent IDH 1/2 Gliomas

NCT05406700 · clinicaltrials.gov ↗

EARLY_PHASE1

Phase

ACTIVE_NOT_RECRUITING

Status

16

Enrollment

OTHER

Sponsor class

Conditions

Low-grade Glioma
IDH2 Gene Mutation
Recurrent Glioma
IDH1 Mutation
Glioma, Malignant

Interventions

DRUG: Niraparib
DRUG: Resection/Treatment with Niraparib

Sponsor

Massachusetts General Hospital

Collaborators

[object Object]